Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 860

The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.

Hyaluronic Acid in the Third Millennium

Open access
Fallacara, Arianna, Baldini, Erika, Manfredini, Stefano, Vertuani, Silvia · 2018 · Polymers

Published version of a preprint

Abstract

Since its first isolation in 1934, hyaluronic acid (HA) has been studied across a variety of research areas. This unbranched glycosaminoglycan consisting of repeating disaccharide units of N-acetyl-d-glucosamine and d-glucuronic acid is almost ubiquitous in humans and in other vertebrates. HA is involved in many key processes, including cell signaling, wound reparation, tissue regeneration, morphogenesis, matrix organization and pathobiology, and has unique physico-chemical properties, such as biocompatibility, biodegradability, mucoadhesivity, hygroscopicity and viscoelasticity. For these reasons, exogenous HA has been investigated as a drug delivery system and treatment in cancer, ophthalmology, arthrology, pneumology, rhinology, urology, aesthetic medicine and cosmetics. To improve and customize its properties and applications, HA can be subjected to chemical modifications: conjugation and crosslinking. The present review gives an overview regarding HA, describing its history, physico-chemical, structural and hydrodynamic properties and biology (occurrence, biosynthesis (by hyaluronan synthases), degradation (by hyaluronidases and oxidative stress), roles, mechanisms of action and receptors). Furthermore, both conventional and recently emerging methods developed for the industrial production of HA and its chemical derivatization are presented. Finally, the medical, pharmaceutical and cosmetic applications of HA and its derivatives are reviewed, reporting examples of HA-based products that currently are on the market or are undergoing further investigations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/polym10070701

Cites

188 of 188 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 188 references

Research works printed but not linked: 69

  1. Boas, 1949, Isolation of hyaluronic acid from the cock’s comb, J. Biol. Chem., 181, 573, 10.1016/S0021-9258(18)56578-9 · doi:10.1016/s0021-9258(18)56578-9
  2. Kaye, 1950, Observations on the chemistry of hyaluronic acid, Biochem. J., 2, 13
  3. Meyer, 1948, Highly viscous sodium hyaluronate, J. Biol. Chem., 176, 993, 10.1016/S0021-9258(19)52716-8 · doi:10.1016/s0021-9258(19)52716-8
  4. Blumberg, 1958, Physicochemical properties of hyaluronic acid formed by Streptococcus haemolyticus, Biochem. J., 70, 1, 10.1042/bj0700001 · doi:10.1042/bj0700001
  5. Pinkus, 1953, The influence of hyaluronic acid and other substances on tensile strength of healing wounds, J. Investig. Dermatol., 21, 365, 10.1038/jid.1953.116 · doi:10.1038/jid.1953.116
  6. Binkhorst, 1981, Advantages and disadvantages of intracamerular Na-hyaluronate (Healon) in intraocular lens surgery, Doc. Ophthalmol., 50, 233, 10.1007/BF00158003 · doi:10.1007/bf00158003
  7. Binkhorst, 1980, Inflammation and intraocular pressure after the use of Healon in intraocular lens surgery, J. Am. Intraocul. Implant Soc., 6, 340, 10.1016/S0146-2776(80)80031-0 · doi:10.1016/s0146-2776(80)80031-0
  8. Percival, 1985, Results of a clinical trial of sodium hyaluronate in lens implantation surgery, J. Am. Intraocul. Implant Soc., 11, 257, 10.1016/S0146-2776(85)80036-7 · doi:10.1016/s0146-2776(85)80036-7
  9. Graue, 1980, The protective effect of Na-hyaluronate to corneal endothelium, Exp. Eye Res., 31, 119, 10.1016/0014-4835(80)90094-9 · doi:10.1016/0014-4835(80)90094-9
  10. Percival, 1981, Protective role of Healon during lens implantation, Trans. Ophthalmol. Soc. UK, 101, 77
  11. Regnault, 1974, Treatment of severe cases of retinal detachment with highly viscous hyaluronic acid, Mod. Probl. Ophthalmol., 12, 378
  12. Kanski, 1975, Intravitreal hyaluronic acid injection. A long-term clinical evaluation, Br. J. Ophthalmol., 59, 255, 10.1136/bjo.59.5.255 · doi:10.1136/bjo.59.5.255
  13. Auer, 1980, Effect of hyaluronic acid in naturally occurring and experimentally induced osteoarthritis, Am. J. Vet. Res., 41, 568, 10.2460/ajvr.1980.41.04.568 · doi:10.2460/ajvr.1980.41.04.568
  14. Leardini, 1988, Intra-articular injections of hyaluronic acid in the treatment of painful shoulder, Clin. Ther., 10, 521
  15. Laurent, 1987, Hyaluronan and healing of tympanic membrane perforations. An experimental study, Acta Otolaryngol. Suppl., 442, 54
  16. King, 1991, Beneficial actions of exogenous hyaluronic acid on wound healing, Surgery, 109, 76
  17. Lin, 1994, Hyaluronic acid-filled mammary implants: An experimental study, Plast. Reconstr. Surg., 94, 306, 10.1097/00006534-199408000-00014 · doi:10.1097/00006534-199408000-00014
  18. Benedetti, 1990, Microspheres of hyaluronic acid esters—Fabrication methods and in vitro hydrocortisone release, J. Control. Release, 13, 33, 10.1016/0168-3659(90)90072-2 · doi:10.1016/0168-3659(90)90072-2
  19. Camber, 1989, Sodium hyaluronate as an ophthalmic vehicle: Some factors governing its effect on the ocular absorption of pilocarpine, Curr. Eye Res., 8, 563, 10.3109/02713688908995755 · doi:10.3109/02713688908995755
  20. Geiger, 2017, Mixtures of hyaluronic acid and liposomes for drug delivery: Phase behavior, microstructure and mobility of liposomes, Int. J. Pharm., 523, 246, 10.1016/j.ijpharm.2017.03.029 · doi:10.1016/j.ijpharm.2017.03.029
  21. Fallacara, A., Vertuani, S., Panozzo, G., Pecorelli, A., Valacchi, G., and Manfredini, S. (2017). Novel Artificial Tears Containing Cross-Linked Hyaluronic Acid: An In Vitro Re-Epithelialization Study. Molecules, 22. · doi:10.3390/molecules22122104
  22. Fallacara, 2017, Hyaluronic acid fillers in soft tissue regeneration, Facial Plast. Surg., 33, 87, 10.1055/s-0036-1597685 · doi:10.1055/s-0036-1597685
  23. Scott, 1989, Secondary structures in hyaluronan solutions: Chemical and biological implications, Ciba Found. Symp., 143, 6
  24. Laurent, 1989, The biology of hyaluronan. Introduction, Ciba Found. Symp., 143, 1
  25. Cleland, 1968, Ionic polysaccharides. II. Comparison of polyelectrolyte behavior of hyaluronate with that of carboxymethyl cellulose, Biopolymers, 6, 1519, 10.1002/bip.1968.360061102 · doi:10.1002/bip.1968.360061102
  26. Helfet, A.J. (1974). The physical properties of synovial fluid and the special role of hyaluronic acid. Disorders of the Knee, J.B. Lippincott Company.
  27. Rwei, 2008, Viscoelasticity and wearability of hyaluronate solutions, Biochem. Eng. J., 40, 211, 10.1016/j.bej.2007.12.021 · doi:10.1016/j.bej.2007.12.021
  28. Maleki, 2008, Effect of pH on the behavior of hyaluronic acid in dilute and semidilute aqueous solutions, Macromol. Symp., 274, 131, 10.1002/masy.200851418 · doi:10.1002/masy.200851418
  29. Ghosh, 1993, Conformational contraction and hydrolysis of hyaluronate in sodium hydroxide solutions, Macromolecules, 26, 4685, 10.1021/ma00069a042 · doi:10.1021/ma00069a042
  30. 1995, Non-Newtonian properties of hyaluronic acid aqueous solution. Colloids Surf. A Physicochem, Eng. Asp., 97, 197, 10.1016/0927-7757(95)03097-W · doi:10.1016/0927-7757(95)03097-w
  31. Gura, 1998, Specific degradation of hyaluronic acid and its rheological properties, Polym. Degrad. Stab., 59, 297, 10.1016/S0141-3910(97)00194-8 · doi:10.1016/s0141-3910(97)00194-8
  32. Robert, 2010, Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging, Pathol. Biol., 58, 187, 10.1016/j.patbio.2009.09.010 · doi:10.1016/j.patbio.2009.09.010
  33. Zhang, 2016, Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion, J. Exp. Clin. Cancer Res., 35, 181, 10.1186/s13046-016-0458-0 · doi:10.1186/s13046-016-0458-0
  34. Schiller, 1995, Action of hypochlorous acid on polymeric components of cartilage. Use of 13C NMR spectroscopy, Z. Naturforsch. C, 50, 721, 10.1515/znc-1995-9-1020 · doi:10.1515/znc-1995-9-1020
  35. Research, G.V. (2018, March 08). Hyaluronic Acid Market Size Worth USD 15.4 Billion by 2025|CAGR: 8.8%. Available online: https://www.grandviewresearch.com/press-release/global-hyaluronic-acid-market.
  36. Rakkhumkaew, 2013, Hyaluronan synthesis in cultured tobacco cells (BY-2) expressing a chlorovirus enzyme: Cytological studies, Biotechnol. Bioeng., 110, 1174, 10.1002/bit.24783 · doi:10.1002/bit.24783
  37. DeAngelis, 2008, Monodisperse hyaluronan polymers: Synthesis and potential applications, Curr. Pharm. Biotechnol., 9, 246, 10.2174/138920108785161550 · doi:10.2174/138920108785161550
  38. Shimojo, 2015, The crosslinking degree controls the mechanical, rheological, and swelling properties of hyaluronic acid microparticles, J. Biomed. Mater. Res. A, 103, 730, 10.1002/jbm.a.35225 · doi:10.1002/jbm.a.35225
  39. Kaur, 2006, Repair of tympanic membrane perforation by topical application of 1% sodium hyaluronate, Indian J. Otolaryngol. Head Neck Surg., 58, 241, 10.1007/BF03050829 · doi:10.1007/bf03050829
  40. Gelardi, 2013, Effect of sodium hyaluronate on mucociliary clearance after functional endoscopic sinus surgery, Eur. Ann. Allergy Clin. Immunol., 45, 103
  41. Maleki, 2007, Characterization of the chemical degradation of hyaluronic acid during chemical gelation in the presence of different cross-linker agents, Carbohydr. Res., 342, 2776, 10.1016/j.carres.2007.08.021 · doi:10.1016/j.carres.2007.08.021
  42. Sigen, 2018, A facile one-pot synthesis of acrylated hyaluronic acid, Chem. Commun., 54, 1081, 10.1039/C7CC08648B · doi:10.1039/c7cc08648b
  43. Pravata, 2008, New amphiphilic lactic acid oligomer–hyaluronan conjugates: Synthesis and physicochemical characterization, Biomacromolecules, 9, 340, 10.1021/bm700843m · doi:10.1021/bm700843m
  44. Steiner, 2006, Synthesis and characterization of new biodegradable hyaluronan alkyl derivatives, Biopolymers, 82, 74, 10.1002/bip.20461 · doi:10.1002/bip.20461
  45. Marchal, 2006, New physically and chemically crosslinked hyaluronate (HA)-based hydrogels for cartilage repair, J. Biomed. Mater. Res. A, 76, 416
  46. Hirano, 2005, Preparation of the methyl ester of hyaluronan and its enzymatic degradation, Carbohydr. Res., 340, 2297, 10.1016/j.carres.2005.07.016 · doi:10.1016/j.carres.2005.07.016
  47. Bergman, 2007, Hyaluronic acid derivatives prepared in aqueous media by triazine-activated amidation, Biomacromolecules, 8, 2190, 10.1021/bm0701604 · doi:10.1021/bm0701604
  48. Crescenzi, 2002, NMR structural study of hydrogels based on partially deacetylated hyaluronan, Macromol. Biosci., 2, 272, 10.1002/1616-5195(200208)2:6<272::AID-MABI272>3.0.CO;2-V · doi:10.1002/1616-5195(200208)2:6<272::aid-mabi272>3.0.co;2-v
  49. Mangano, 2017, Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone, Exp. Ther. Med., 14, 2439, 10.3892/etm.2017.4810 · doi:10.3892/etm.2017.4810
  50. Chen, 2018, Conjugation of paclitaxel to C-6 hexanediamine-modified hyaluronic acid for targeted drug delivery to enhance antitumor efficacy, Carbohydr. Polym., 181, 150, 10.1016/j.carbpol.2017.09.017 · doi:10.1016/j.carbpol.2017.09.017
  51. Fatnassi, 2014, Optimization of spray-dried hyaluronic acid microspheres to formulate drug-loaded bone substitute materials, Powder Technol., 255, 44, 10.1016/j.powtec.2013.08.027 · doi:10.1016/j.powtec.2013.08.027
  52. Simsolo, 2018, Formulation and evaluation of organogels containing hyaluronan microparticles for topical delivery of caffeine, AAPS PharmSciTech, 19, 1367, 10.1208/s12249-018-0955-x · doi:10.1208/s12249-018-0955-x
  53. Esposito, 2005, Hyaluronan-based microspheres as tools for drug delivery: A comparative study, Int. J. Pharm., 288, 35, 10.1016/j.ijpharm.2004.09.001 · doi:10.1016/j.ijpharm.2004.09.001
  54. Pirard, 2005, Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: A meta-analysis of the recent studies, Arch. Dermatol. Res., 297, 185, 10.1007/s00403-005-0601-9 · doi:10.1007/s00403-005-0601-9
  55. Tagliagambe, 2017, Hyaluronic Acid Sodium Salt 0.2% Gel in the Treatment of a Recalcitrant Distal Leg Ulcer: A Case Report, J. Clin. Aesthet. Dermatol., 10, 49
  56. 2005, Hyaluronic acid: A new trend to cure skin injuries an observational study, Rev. Enferm., 28, 53
  57. Sanad, 2017, Chitosan-hyaluronic acid composite sponge scaffold enriched with Andrographolide-loaded lipid nanoparticles for enhanced wound healing, Carbohydr. Polym., 173, 441, 10.1016/j.carbpol.2017.05.098 · doi:10.1016/j.carbpol.2017.05.098
  58. Neumayer, 2008, Effect of a new cohesive ophthalmic viscosurgical device on corneal protection and intraocular pressure in small-incision cataract surgery, J. Cataract Refract. Surg., 34, 1362, 10.1016/j.jcrs.2008.04.018 · doi:10.1016/j.jcrs.2008.04.018
  59. Vandermeer, 2018, Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye: Normal saline vs. artificial tears: A pilot study, J. Fr. Ophtalmol., 41, e51, 10.1016/j.jfo.2017.12.001 · doi:10.1016/j.jfo.2017.12.001
  60. Aragona, 2002, Long term treatment with sodium hyaluronate–containing artificial tears reduces ocular surface damage in patients with dry eye, Br. J. Ophthalmol., 86, 181, 10.1136/bjo.86.2.181 · doi:10.1136/bjo.86.2.181
  61. Laffleur, 2015, Development of novel mucoadhesive hyaluronic acid derivate as lubricant for the treatment of dry eye syndrome, Ther. Deliv., 6, 1211, 10.4155/tde.15.55 · doi:10.4155/tde.15.55
  62. Gerdin, 1997, Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation, J. Intern. Med., 242, 49, 10.1046/j.1365-2796.1997.00173.x · doi:10.1046/j.1365-2796.1997.00173.x
  63. Furnari, 2012, Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: A prospective, randomized, double-blind, controlled study, Ther. Adv. Respir. Dis., 6, 315, 10.1177/1753465812458984 · doi:10.1177/1753465812458984
  64. Nenna, 2011, 7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis, Eur. Respir. J., 38, 1717
  65. Jurkiewicz, 2015, Treatment of recurrent bacterial cystitis by intravesical instillations of hyaluronic acid, Urol. J., 12, 2192
  66. Muhn, 2012, The evolving role of hyaluronic acid fillers for facial volume restoration and contouring: A Canadian overview, Clin. Cosmet. Investig. Dermatol., 5, 147, 10.2147/CCID.S30794 · doi:10.2147/ccid.s30794
  67. Sato, 2009, An effectiveness study of hyaluronic acid [Hyabest® (J)] in the treatment of osteoarthritis of the knee on the patients in the United States, J. New Rem. Clin., 58, 260
  68. Valls, 2015, A low-fat yoghurt supplemented with a rooster comb extract on muscle joint function in adults with mild knee pain: A rondomized, double blind, parallel, placebo-controlled, clinical trial of efficacy, Food Funct., 6, 3531, 10.1039/C5FO00321K · doi:10.1039/c5fo00321k
  69. Larson, B. (2018, June 14). 3D Cell Culture: A Review of Current Techniques. Available online: http://mktg.biotek.com/ news/2015/Fall/featured-application.html.

Cited by

Metadata

Authors
Fallacara, A., Baldini, E., Manfredini, S., & Vertuani, S.
Venue
Polymers
Publisher
MDPI AG
Published
2018-06-25
Volume
10
Issue
7
Pages
701
ISSN
2073-4360 (ISSN-L)
OpenAlex
W2809231499
Cited by
860
References
188
FWCI
23.41
Type
journal article
Language
en
Open access
gold
Funders
  • IRALAB (2016-2018)
  • AMBROSIALAB srl (2017)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.